Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2005 1
2006 1
2008 1
2009 2
2010 2
2011 2
2012 2
2013 4
2014 2
2015 5
2016 1
2018 2
2019 2
2020 1
2021 3
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Absence of blood donors' anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients.
Casale M, Di Girolamo MG, Di Maio N, Tomeo R, Iengo M, Scianguetta S, Palma T, Porcelli F, Misso S, Perrotta S. Casale M, et al. Among authors: di girolamo mg. Ann Hematol. 2024 Feb;103(2):623-629. doi: 10.1007/s00277-023-05473-2. Epub 2023 Sep 27. Ann Hematol. 2024. PMID: 37758964 Free PMC article.
Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review.
Ballestri S, Romagnoli E, Arioli D, Coluccio V, Marrazzo A, Athanasiou A, Di Girolamo M, Cappi C, Marietta M, Capitelli M. Ballestri S, et al. Among authors: di girolamo m. Adv Ther. 2023 Jan;40(1):41-66. doi: 10.1007/s12325-022-02333-9. Epub 2022 Oct 16. Adv Ther. 2023. PMID: 36244055 Free PMC article. Review.
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study.
Pugliese D, Privitera G, Rogai F, Variola A, Viola A, Laterza L, Privitera AC, Allocca M, Bossa F, Cappello M, Daperno M, Lorenzon G, Mazzuoli S, Principi M, Sablich R, Moser L, Ferronato A, Traini S, Tapete G, Bodini G, Di Girolamo M, Grossi L, Mocci G, Ricci C, Saibeni S, Festa S, Spagnuolo R, Cortelezzi CC, Mocciaro F, Rizzello F, Armuzzi A; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Pugliese D, et al. Among authors: di girolamo m. United European Gastroenterol J. 2021 Feb;9(1):102-109. doi: 10.1177/2050640620974308. Epub 2021 Mar 1. United European Gastroenterol J. 2021. PMID: 33203342 Free PMC article.
Semi-Quantitative Ultrasonographic Evaluation of NAFLD.
Ballestri S, Tana C, Di Girolamo M, Fontana MC, Capitelli M, Lonardo A, Cioni G. Ballestri S, et al. Among authors: di girolamo m. Curr Pharm Des. 2020;26(32):3915-3927. doi: 10.2174/1381612826666200417142444. Curr Pharm Des. 2020. PMID: 32303161 Review.
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.
Armuzzi A, Fiorino G, Variola A, Manetti N, Fries W, Orlando A, Maconi G, Bossa F, Cappello M, Biancone L, Cantoro L, Costa F, D'Incà R, Lionetti P, Principi M, Castiglione F, Annunziata ML, Di Sabatino A, Di Girolamo M, Terpin MM, Cortelezzi CC, Saibeni S, Amato A, Ardizzone S, Guidi L, Danese S, Massella A, Ventra A, Rizzuto G, Massari A, Perri F, Annese V; PROSIT Investigators. Armuzzi A, et al. Among authors: di girolamo m. Inflamm Bowel Dis. 2019 Feb 21;25(3):568-579. doi: 10.1093/ibd/izy264. Inflamm Bowel Dis. 2019. PMID: 30137352
Targeted metabolomic profiling in rat tissues reveals sex differences.
Ruoppolo M, Caterino M, Albano L, Pecce R, Di Girolamo MG, Crisci D, Costanzo M, Milella L, Franconi F, Campesi I. Ruoppolo M, et al. Among authors: di girolamo mg. Sci Rep. 2018 Mar 16;8(1):4663. doi: 10.1038/s41598-018-22869-7. Sci Rep. 2018. PMID: 29549307 Free PMC article.
34 results